{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:03:36Z","timestamp":1785798216309,"version":"3.56.0"},"reference-count":6,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>\n                  <jats:bold>Overview of:<\/jats:bold>\nMedicines and Healthcare products Regulatory Agency. Statins: very infrequent reports of myasthenia gravis.<jats:italic>Drug Safety Update<\/jats:italic>\n2023;17(2):1.\n<\/jats:p>","DOI":"10.1136\/dtb.2023.000063","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T13:20:14Z","timestamp":1701523214000},"page":"4-4","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Safety update: statins and myasthenia gravis"],"prefix":"10.1136","volume":"62","member":"239","published-online":{"date-parts":[[2023,12,2]]},"reference":[{"key":"2025082623365194000_62.1.4.1","first-page":"1","article-title":"Statins: very infrequent reports of myasthenia gravis","volume":"17","year":"2023","journal-title":"Drug Safety Update"},{"key":"2025082623365194000_62.1.4.2","unstructured":"European Medicines Agency . PRAC recommendations on signals [online]. 2023. Available: https:\/\/www.ema.europa.eu\/en\/documents\/prac-recommendation\/prac-recommendations-signals-adopted-9-12-january-2023-prac-meeting_en.pdf [Accessed 07 Nov 2023]."},{"key":"2025082623365194000_62.1.4.3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(02)09846-X","article-title":"Statins, fibrates, and ocular myasthenia","volume":"360","author":"Parmar","year":"2002","journal-title":"Lancet"},{"key":"2025082623365194000_62.1.4.4","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21074"},{"key":"2025082623365194000_62.1.4.5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/mus.26637","article-title":"Statin-induced myasthenia: a disproportionality analysis of the WHO\u2019s vigibase pharmacovigilance database","volume":"60","author":"Gras-Champel","year":"2019","journal-title":"Muscle Nerve"},{"key":"2025082623365194000_62.1.4.6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011124"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2023.000063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:37:00Z","timestamp":1756276620000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2023.000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,2]]},"references-count":6,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,27]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1136\/dtb.2023.000063"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2023.000063","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"value":"0012-6543","type":"print"},{"value":"1755-5248","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,2]]}}}